HLA Typing Market to Reach USD 2.4 Billion by 2035 Amid Technological Advancements in Diagnostics

The global HLA Typing Market is experiencing steady expansion as the demand for precise, reliable, and high-throughput typing solutions continues to rise. Valued at USD 1.3 billion in 2025, the market is expected to reach USD 2.4 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.7% over the forecast period. The primary drivers of this growth include the increasing number of organ transplants worldwide, rising prevalence of chronic and autoimmune diseases, and the growing importance of personalized medicine.

HLA typing plays a critical role in ensuring compatibility between donors and recipients, reducing the risk of transplant rejection, and facilitating disease association studies. Beyond transplantation, HLA typing is gaining traction in drug hypersensitivity testing and vaccine development, further broadening the scope of applications for both research and clinical diagnostics.

Technological Advancements Driving Market Expansion

The HLA typing industry is rapidly evolving with the adoption of molecular-based platforms and next-generation sequencing technologies. The transition from serology-based testing to DNA-based methodologies has enabled laboratories to achieve higher sensitivity, improved accuracy, and faster turnaround times. Molecular assays, representing 52.4% of the technique segment, have become the dominant method due to their ability to detect complex polymorphic variations efficiently.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/reports/sample/rep-gb-18098

Automation integration in HLA typing workflows has enhanced throughput and reduced human error. Reagents and consumables, which hold the largest share at 46.7% of the product segment, are benefiting from improved formulations that increase shelf life, reliability, and compatibility with automated platforms. Leading manufacturers are continuously refining these products to meet growing clinical demands.

Segmental Insights: Products and Applications

Within the product type segment, reagents and consumables remain central to market growth because of their recurring use across various testing platforms. These materials are indispensable for routine diagnostic procedures and research studies, as they support the high volume of testing required in hospitals, transplant centers, and diagnostic laboratories. Continuous innovation in formulation and quality control has reinforced confidence in these products among healthcare providers, ensuring sustained adoption.

The diagnostics segment, accounting for 59.3% of the application category, leads the market due to its vital role in transplantation compatibility testing and disease risk assessment. Healthcare providers increasingly rely on HLA typing to reduce complications and improve patient survival rates. Government-backed transplant programs, reimbursement policies, and the integration of molecular assays into routine clinical workflows have bolstered this segment, with ongoing advancements in sequencing technology and data interpretation tools enhancing diagnostic precision.

Expanding Role of Molecular Assays

Molecular assays, including PCR-based and next-generation sequencing (NGS) platforms, are shaping the future of HLA typing. These assays offer high sensitivity, rapid results, and the ability to analyze multiple samples simultaneously. Innovations such as the integration of microfluidics, robotics, and bioinformatics tools have significantly improved the efficiency of HLA typing procedures, making them indispensable in both research and clinical applications.

The molecular approach is increasingly utilized in personalized immunotherapy, allowing researchers to fill gaps in HLA libraries and identify variants associated with specific diseases. This capability improves the accuracy of organ transplants and supports vaccine design, highlighting the critical role of HLA typing in precision medicine.

Market Dynamics: Opportunities and Challenges

The HLA typing market is benefiting from supportive regulatory frameworks and expanding healthcare infrastructure, particularly in emerging economies. Manufacturers are focusing on enhancing assay sensitivity, automating workflows, and expanding their product portfolios to meet growing clinical demand. Investments in research and development are fostering the adoption of next-generation sequencing and bioinformatics-driven solutions, further boosting market growth.

However, the market faces challenges such as high costs associated with advanced testing platforms, the need for specialized training, and varying adoption rates across different regions. Despite these obstacles, the overall market outlook remains positive, driven by the critical importance of HLA typing in improving patient outcomes and expanding clinical applications.

Request Market Research Draft Report: https://www.futuremarketinsights.com/customization-available/rep-gb-18098

Regional Market Insights

North America continues to dominate the HLA typing market, with the United States expected to generate USD 2.4 billion by 2035 and grow at a CAGR of 6.9% from 2025 to 2035. The region benefits from strong government support for organ donation and transplantation programs, along with widespread adoption of advanced diagnostic technologies.

In Europe, the United Kingdom is poised for steady growth, driven by high adoption rates of advanced HLA typing platforms and the increasing prevalence of chronic diseases. The market is anticipated to achieve a CAGR of 5.8%, highlighting the role of healthcare innovation and regulatory support in maintaining steady demand.

Asia-Pacific presents significant opportunities, with China expected to grow at a CAGR of 7.1% over the forecast period. Improved healthcare infrastructure, reimbursement policies, and rising disposable incomes are contributing to market expansion. Japan and South Korea also hold lucrative positions, with growth rates of 6.5% and 4.7%, respectively, supported by the increasing adoption of molecular diagnostics and HLA typing in clinical practice.

Competitive Landscape and Key Players

The global HLA typing market is highly competitive, with established and emerging players actively expanding their product offerings and technological capabilities. Leading companies include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., F.Hoffmann-La Roche Ltd., Immucor, Inc., bioMerieux S.A., CareDx, Inc., Hologic, Inc., and Olerup International AB. These players employ a combination of organic growth, partnerships, and technological innovation to strengthen their market presence.

Several notable developments highlight the market’s dynamism. In October 2025, Eurobio Scientific’s GenDx launched NGS-Turbo, utilizing Oxford Nanopore Technologies for rapid HLA typing. Omixon introduced the NanoTYPE RUO Multiplex kit compatible with the MinION Platform, enhancing precision and throughput. Metropolis Healthcare revealed the NextGen HLA test in April 2025, employing NGS technology to improve donor-recipient matching. Bio-Rad and CareDx also received regulatory approvals for their advanced kits and software platforms, further consolidating their positions as key innovators.

Related Reports:

Clinical Alarm Management Market: https://www.futuremarketinsights.com/reports/clinical-alarm-management-market

Pneumonia Diagnostics Market: https://www.futuremarketinsights.com/reports/pneumonia-diagnostic-market

Hyaluronic Acid Products Market: https://www.futuremarketinsights.com/reports/hyaluronic-acid-products-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs | YouTube